Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1985 May;78(5):391–396. doi: 10.1177/014107688507800509

Chronic hepatitis: a review.

R A Bradbear
PMCID: PMC1289721  PMID: 3921709

Full text

PDF
391

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdi W., Millan J. C., Mezey E. Sampling variability on percutaneous liver biopsy. Arch Intern Med. 1979 Jun;139(6):667–669. [PubMed] [Google Scholar]
  2. Aldershvile J., Dietrichson O., Skinhøj P., Kryger P., Mathiesen L. R., Christoffersen P., Nielsen J. O. Chronic persistent hepatitis: serological classification and meaning of the hepatitis B e system. Hepatology. 1982 Mar-Apr;2(2):243–246. doi: 10.1002/hep.1840020209. [DOI] [PubMed] [Google Scholar]
  3. Baggenstoss A. H., Soloway R. D., Summerskill W. H., Elveback L. R., Schoenfield L. J. Chronic active liver disease. The range of histologic lesions, their response to treatment, and evolution. Hum Pathol. 1972 Jun;3(2):183–198. doi: 10.1016/s0046-8177(72)80072-8. [DOI] [PubMed] [Google Scholar]
  4. Bamber M., Murray A. K., Weller I. V., Morelli A., Scheuer P. J., Thomas H. C., Sherlock S. Clinical and histological features of a group of patients with sporadic non-A, non-B hepatitis. J Clin Pathol. 1981 Oct;34(10):1175–1180. doi: 10.1136/jcp.34.10.1175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Becker M. D., Baptista A., Scheuer P. J., Sherlock S. Prognosis of chronic persistent hepatitis. Lancet. 1970 Jan 10;1(7637):53–57. doi: 10.1016/s0140-6736(70)91843-x. [DOI] [PubMed] [Google Scholar]
  6. Berman M., Alter H. J., Ishak K. G., Purcell R. H., Jones E. A. The chronic sequelae of non-A, non-B hepatitis. Ann Intern Med. 1979 Jul;91(1):1–6. doi: 10.7326/0003-4819-91-1-1. [DOI] [PubMed] [Google Scholar]
  7. Bradbear R. A., Robinson W. N., Cooksley W. G., Halliday J. W., Harris O. D., Powell L. W. Are the causes and presentation of chronic hepatitis changing? An analysis of 104 cases over 15 years. Q J Med. 1984 Spring;53(210):279–288. [PubMed] [Google Scholar]
  8. COWLING D. C., MACKAY I. R., TAFT L. I. Lupoid hepatitis. Lancet. 1956 Dec 29;271(6957):1323–1326. doi: 10.1016/s0140-6736(56)91483-0. [DOI] [PubMed] [Google Scholar]
  9. Chadwick R. G., Galizzi J., Jr, Heathcote J., Lyssiotis T., Cohen B. J., Scheuer P. J., Sherlock S. Chronic persistent hepatitis: hepatitis B virus markers and histological follow-up. Gut. 1979 May;20(5):372–377. doi: 10.1136/gut.20.5.372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Czaja A. J., Davis G. L., Ludwig J., Taswell H. F. Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg-negative chronic active hepatitis. Hepatology. 1984 Jul-Aug;4(4):622–627. doi: 10.1002/hep.1840040409. [DOI] [PubMed] [Google Scholar]
  11. Davis G. L., Hoofnagle J. H., Waggoner J. G. Spontaneous reactivation of chronic hepatitis B virus infection. Gastroenterology. 1984 Feb;86(2):230–235. [PubMed] [Google Scholar]
  12. De Groote J., Desmet V. J., Gedigk P., Korb G., Popper H., Poulsen H., Scheuer P. J., Schmid M., Thaler H., Uehlinger E. A classification of chronic hepatitis. Lancet. 1968 Sep 14;2(7568):626–628. doi: 10.1016/s0140-6736(68)90710-1. [DOI] [PubMed] [Google Scholar]
  13. Dietrichson O., Christoffersen P. The prognosis of chronic aggressive hepatitis. A clinical and morphological follow-up study. Scand J Gastroenterol. 1977;12(3):289–295. doi: 10.3109/00365527709180930. [DOI] [PubMed] [Google Scholar]
  14. Dietrichson O. Chronic persistent hepatitis. A clinical, serological, and prognostic study. Scand J Gastroenterol. 1975;10(3):249–255. [PubMed] [Google Scholar]
  15. Dudley F. J., Scheuer P. J., Sherlock S. Natural history of hepatitis-associated antigen-positive chronic liver disease. Lancet. 1972 Dec 30;2(7792):1388–1393. doi: 10.1016/s0140-6736(72)92963-7. [DOI] [PubMed] [Google Scholar]
  16. Feinstone S. M., Hoofnagle J. H. Non-A, maybe-B hepatitis. N Engl J Med. 1984 Jul 19;311(3):185–189. doi: 10.1056/NEJM198407193110311. [DOI] [PubMed] [Google Scholar]
  17. Felsher B. F., Carpio N. M. Chronic persistent hepatitis and unconjugated hyperbilirubinemia. Gastroenterology. 1979 Feb;76(2):248–252. [PubMed] [Google Scholar]
  18. Govindarajan S., Chin K. P., Redeker A. G., Peters R. L. Fulminant B viral hepatitis: role of delta agent. Gastroenterology. 1984 Jun;86(6):1417–1420. [PubMed] [Google Scholar]
  19. Hodges J. R., Millward-Sadler G. H., Wright R. Chronic active hepatitis: the spectrum of disease. Lancet. 1982 Mar 6;1(8271):550–552. doi: 10.1016/s0140-6736(82)92056-6. [DOI] [PubMed] [Google Scholar]
  20. Hoofnagle J. H. Chronic type B hepatitis. Gastroenterology. 1983 Feb;84(2):422–424. [PubMed] [Google Scholar]
  21. Koretz R. L., Lewin K. J., Higgins J., Fagen N. D., Gitnick G. L. Chronic active hepatitis. Who meets treatment criteria? Dig Dis Sci. 1980 Sep;25(9):695–699. doi: 10.1007/BF01308329. [DOI] [PubMed] [Google Scholar]
  22. Liaw Y. F., Chu C. M., Chen T. J., Lin D. Y., Chang-Chien C. S., Wu C. S. Chronic lobular hepatitis: a clinicopathological and prognostic study. Hepatology. 1982 Mar-Apr;2(2):258–262. doi: 10.1002/hep.1840020213. [DOI] [PubMed] [Google Scholar]
  23. Mackay I. R. Immunological aspects of chronic active hepatitis. Hepatology. 1983 Sep-Oct;3(5):724–728. doi: 10.1002/hep.1840030517. [DOI] [PubMed] [Google Scholar]
  24. Moestrup T., Hansson B. G., Widell A., Nordenfelt E. Clinical aspects of delta infection. Br Med J (Clin Res Ed) 1983 Jan 8;286(6359):87–90. doi: 10.1136/bmj.286.6359.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Okuno T., Okanoue T., Takino T., Mori K. Prognostic significance of bridging necrosis in chronic active hepatitis. Gastroenterol Jpn. 1983 Dec;18(6):577–584. doi: 10.1007/BF02774698. [DOI] [PubMed] [Google Scholar]
  26. Popper H. Changing concepts of the evolution of chronic hepatitis and the role of piecemeal necrosis. Hepatology. 1983 Sep-Oct;3(5):758–762. doi: 10.1002/hep.1840030522. [DOI] [PubMed] [Google Scholar]
  27. Popper H., Schaffner F. Chronic hepatitis: taxonomic, etiologic, and therapeutic problems. Prog Liver Dis. 1976;5:531–558. [PubMed] [Google Scholar]
  28. Raimondo G., Longo G., Squadrito G. Exacerbation of chronic liver disease due to hepatitis B surface antigen after delta infection. Br Med J (Clin Res Ed) 1983 Mar 12;286(6368):845–845. doi: 10.1136/bmj.286.6368.845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Raimondo G., Smedile A., Gallo L., Balbo A., Ponzetto A., Rizzetto M. Multicentre study of prevalence of HBV-associated delta infection and liver disease in drug-addicts. Lancet. 1982 Jan 30;1(8266):249–251. doi: 10.1016/s0140-6736(82)90976-x. [DOI] [PubMed] [Google Scholar]
  30. Rakela J., Redeker A. G. Chronic liver disease after acute non-A, non-B viral hepatitis. Gastroenterology. 1979 Dec;77(6):1200–1202. [PubMed] [Google Scholar]
  31. Realdi G., Alberti A., Rugge M., Rigoli A. M., Tremolada F., Schivazappa L., Ruol A. Long-term follow-up of acute and chronic non-A, non-B post-transfusion hepatitis: evidence of progression to liver cirrhosis. Gut. 1982 Apr;23(4):270–275. doi: 10.1136/gut.23.4.270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Rizzetto M. The delta agent. Hepatology. 1983 Sep-Oct;3(5):729–737. doi: 10.1002/hep.1840030518. [DOI] [PubMed] [Google Scholar]
  33. SAINT E. G., KING W. E., JOSKE R. A., FINCKH E. S. The course of infectious hepatitis with special reference to prognosis and the chronic stage. Australas Ann Med. 1953 Nov;2(2):113–127. doi: 10.1111/imj.1953.2.2.113. [DOI] [PubMed] [Google Scholar]
  34. Schalm S. W. Treatment of chronic hepatitis type virus B. Hepatogastroenterology. 1984 Feb;31(1):12–16. [PubMed] [Google Scholar]
  35. Scheuer P. J. Chronic hepatitis: a problem for the pathologist. Histopathology. 1977 Jan;1(1):5–19. doi: 10.1111/j.1365-2559.1977.tb01640.x. [DOI] [PubMed] [Google Scholar]
  36. Seto B., Coleman W. G., Jr, Iwarson S., Gerety R. J. Detection of reverse transcriptase activity in association with the non-A, non-B hepatitis agent(s). Lancet. 1984 Oct 27;2(8409):941–943. doi: 10.1016/s0140-6736(84)91163-2. [DOI] [PubMed] [Google Scholar]
  37. Sánchez-Tapias J. M., Vilar J. H., Costa J., Bruguera M., Ballesta A. M., Rodés J. Natural history of chronic persistent hepatitis B. Relationship between hepatitis B virus replication and the course of the disease. J Hepatol. 1985;1(1):15–27. doi: 10.1016/s0168-8278(85)80064-7. [DOI] [PubMed] [Google Scholar]
  38. Theodossi A., Skene A. M., Portmann B., Knill-Jones R. P., Patrick R. S., Tate R. A., Kealey W., Jarvis K. J., O'Brian D. J., Williams R. Observer variation in assessment of liver biopsies including analysis by kappa statistics. Gastroenterology. 1980 Aug;79(2):232–241. [PubMed] [Google Scholar]
  39. Thomas H. C., Lok A. S. The immunopathology of autoimmune and hepatitis B virus-induced chronic hepatitis. Semin Liver Dis. 1984 Feb;4(1):36–46. doi: 10.1055/s-2008-1040644. [DOI] [PubMed] [Google Scholar]
  40. Vento S., Hegarty J. E., Bottazzo G., Macchia E., Williams R., Eddleston A. L. Antigen specific suppressor cell function in autoimmune chronic active hepatitis. Lancet. 1984 Jun 2;1(8388):1200–1204. doi: 10.1016/s0140-6736(84)91691-x. [DOI] [PubMed] [Google Scholar]
  41. Weller I. V., Karayiannis P., Lok A. S., Montano L., Bamber M., Thomas H. C., Sherlock S. Significance of delta agent infection in chronic hepatitis B virus infection: a study in British carriers. Gut. 1983 Nov;24(11):1061–1063. doi: 10.1136/gut.24.11.1061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Whittingham S., Mathews J. D., Schanfield M. S., Tait B. D., Mackay I. R. Interaction of HLA and Gm in autoimmune chronic active hepatitis. Clin Exp Immunol. 1981 Jan;43(1):80–86. [PMC free article] [PubMed] [Google Scholar]
  43. Wiedmann K. H., Bartholemew T. C., Brown D. J., Thomas H. C. Liver membrane antibodies detected by immunoradiometric assay in acute and chronic virus-induced and autoimmune liver disease. Hepatology. 1984 Mar-Apr;4(2):199–204. doi: 10.1002/hep.1840040206. [DOI] [PubMed] [Google Scholar]
  44. Wilkinson S. P., Portmann B., Cochrane A. M., Tee D. E., Williams R. Clinical course of chronic lobular hepatitis: report of five cases. Q J Med. 1978 Oct;47(188):421–429. [PubMed] [Google Scholar]
  45. Wright E. C., Seeff L. B., Berk P. D., Jones A., Plotz P. H. Treatment of chronic active hepatitis. An analysis of three controlled trials. Gastroenterology. 1977 Dec;73(6):1422–1430. [PubMed] [Google Scholar]
  46. Wu P. C., Lai C. L., Lam K. C., Ho J. Prednisolone in HBsAg-positive chronic active hepatitis: histologic evaluation in a controlled prospective study. Hepatology. 1982 Nov-Dec;2(6):777–783. doi: 10.1002/hep.1840020605. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES